- Home
- Publications
- Publication Search
- Publication Details
Title
Predicting survival in chronic lymphocytic leukemia
Authors
Keywords
-
Journal
Expert Review of Anticancer Therapy
Volume 12, Issue 3, Pages 393-403
Publisher
Informa UK Limited
Online
2012-02-28
DOI
10.1586/era.12.2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Chronic lymphocytic leukemia and treatment resistance in cancer: The role of the p53 pathway
- (2011) Thorsten Zenz et al. CELL CYCLE
- Modern and conventional prognostic markers of chronic lymphocytic leukaemia in the everyday haematological practice
- (2011) Michael Doubek et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Mutational Status of theTP53Gene As a Predictor of Response and Survival in Patients With Chronic Lymphocytic Leukemia: Results From the LRF CLL4 Trial
- (2011) David Gonzalez et al. JOURNAL OF CLINICAL ONCOLOGY
- Clinico-prognostic implications of simultaneous increased serum levels of soluble CD23 and β2-microglobulin in B-cell chronic lymphocytic leukemia
- (2010) Stefano Molica et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Prognostic factors identified three risk groups in the LRF CLL4 trial, independent of treatment allocation
- (2010) D. Oscier et al. HAEMATOLOGICA
- TP53Mutation and Survival in Chronic Lymphocytic Leukemia
- (2010) Thorsten Zenz et al. JOURNAL OF CLINICAL ONCOLOGY
- Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial
- (2010) M Hallek et al. LANCET
- Immunohistochemical detection of ZAP70 in chronic lymphocytic leukemia predicts immunoglobulin heavy chain gene mutation status and time to progression
- (2010) Joan H Admirand et al. MODERN PATHOLOGY
- De novo deletion 17p13.1 chronic lymphocytic leukemia shows significant clinical heterogeneity: the M. D. Anderson and Mayo Clinic experience
- (2009) C. S. Tam et al. BLOOD
- Beta2-microglobulin is a better predictor of treatment-free survival in patients with chronic lymphocytic leukaemia if adjusted according to glomerular filtration rate
- (2009) Julio Delgado et al. BRITISH JOURNAL OF HAEMATOLOGY
- Chemoimmunotherapy may overcome the adverse prognostic significance of 11q deletion in previously untreated patients with chronic lymphocytic leukemia
- (2009) Apostolia-Maria Tsimberidou et al. CANCER
- Correlation of flow cytometrically determined expression of ZAP-70 using the SBZAP antibody with IgVH mutation status and cytogenetics in 1,229 patients with chronic lymphocytic leukemia
- (2009) Wolfgang Kern et al. CYTOMETRY PART B-CLINICAL CYTOMETRY
- Predictive value of 2-microglobulin ( 2-m) levels in chronic lymphocytic leukemia since Binet A stages
- (2009) M. Gentile et al. HAEMATOLOGICA
- Characteristics Associated With Important Clinical End Points in Patients With Chronic Lymphocytic Leukemia at Initial Treatment
- (2009) William G. Wierda et al. JOURNAL OF CLINICAL ONCOLOGY
- Percentage of Smudge Cells on Routine Blood Smear Predicts Survival in Chronic Lymphocytic Leukemia
- (2009) Grzegorz S. Nowakowski et al. JOURNAL OF CLINICAL ONCOLOGY
- Relevance of the immunoglobulin VH somatic mutation status in patients with chronic lymphocytic leukemia treated with fludarabine, cyclophosphamide, and rituximab (FCR) or related chemoimmunotherapy regimens
- (2008) K. I. Lin et al. BLOOD
- CD38 expression in chronic lymphocytic leukemia is regulated by the tumor microenvironment
- (2008) P. E. M. Patten et al. BLOOD
- Relative value of ZAP-70, CD38, and immunoglobulin mutation status in predicting aggressive disease in chronic lymphocytic leukemia
- (2008) L. Z. Rassenti et al. BLOOD
- Long-term results of the fludarabine, cyclophosphamide, and rituximab regimen as initial therapy of chronic lymphocytic leukemia
- (2008) C. S. Tam et al. BLOOD
- Monoallelic TP53 inactivation is associated with poor prognosis in chronic lymphocytic leukemia: results from a detailed genetic characterization with long-term follow-up
- (2008) T. Zenz et al. BLOOD
- Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines
- (2008) M. Hallek et al. BLOOD
- Chronic lymphocytic leukaemia CD20 expression is dependent on the genetic subtype: a study of quantitative flow cytometry and fluorescent in-situ hybridization in 510 patients
- (2008) Constantine S. Tam et al. BRITISH JOURNAL OF HAEMATOLOGY
- Validation of a new prognostic index for patients with chronic lymphocytic leukemia
- (2008) Tait D. Shanafelt et al. CANCER
- Fludarabine, Cyclophosphamide, and Mitoxantrone as Initial Therapy of Chronic Lymphocytic Leukemia: High Response Rate and Disease Eradication
- (2008) F. Bosch et al. CLINICAL CANCER RESEARCH
- The detection of TP53 mutations in chronic lymphocytic leukemia independently predicts rapid disease progression and is highly correlated with a complex aberrant karyotype
- (2008) F Dicker et al. LEUKEMIA
- A subset of Binet stage A CLL patients with TP53 abnormalities and mutated IGHV genes have stable disease
- (2008) O G Best et al. LEUKEMIA
- Comorbid conditions and survival in unselected, newly diagnosed patients with chronic lymphocytic leukemia
- (2008) Paul Thurmes et al. LEUKEMIA & LYMPHOMA
- Controversies in the front-line management of chronic lymphocytic leukemia
- (2008) Chadi Nabhan et al. LEUKEMIA RESEARCH
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now